Viewing Study NCT03466320


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-01-29 @ 1:52 AM
Study NCT ID: NCT03466320
Status: COMPLETED
Last Update Posted: 2021-05-04
First Post: 2018-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2
Sponsor: Celyad Oncology SA
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None AML View
None MDS View
Keywords: